Faïza Chermak

2.9k total citations
27 papers, 2.0k citations indexed

About

Faïza Chermak is a scholar working on Epidemiology, Hepatology and Surgery. According to data from OpenAlex, Faïza Chermak has authored 27 papers receiving a total of 2.0k indexed citations (citations by other indexed papers that have themselves been cited), including 21 papers in Epidemiology, 20 papers in Hepatology and 5 papers in Surgery. Recurrent topics in Faïza Chermak's work include Liver Disease Diagnosis and Treatment (21 papers), Liver Disease and Transplantation (9 papers) and Liver Diseases and Immunity (8 papers). Faïza Chermak is often cited by papers focused on Liver Disease Diagnosis and Treatment (21 papers), Liver Disease and Transplantation (9 papers) and Liver Diseases and Immunity (8 papers). Faïza Chermak collaborates with scholars based in France, Hong Kong and Australia. Faïza Chermak's co-authors include Juliette Foucher, Victor de Lédinghen, Julien Vergniol, Wassil Merrouche, Jean‐Baptiste Hiriart, Brigitte Le Bail, Christophe Cassinotto, Vincent Wai‐Sun Wong, Grace Lai–Hung Wong and Paul Cheung‐Lung Choi and has published in prestigious journals such as Hepatology, Radiology and Journal of Hepatology.

In The Last Decade

Faïza Chermak

26 papers receiving 2.0k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Faïza Chermak France	15	1.9k	1.4k	326	243	160	27	2.0k
I. Fouchard‐Hubert France	18	1.9k 1.0×	1.5k 1.0×	253 0.8×	207 0.9×	142 0.9×	39	2.0k
Catherine Douvin France	14	2.5k 1.3×	2.0k 1.4×	255 0.8×	292 1.2×	148 0.9×	20	2.6k
Yen Ngo France	24	1.9k 1.1×	1.5k 1.1×	297 0.9×	194 0.8×	107 0.7×	52	2.1k
Ethan Sy United States	12	1.5k 0.8×	912 0.7×	386 1.2×	194 0.8×	137 0.9×	16	1.6k
Brandon Ang United States	8	1.3k 0.7×	774 0.6×	357 1.1×	135 0.6×	184 1.1×	10	1.4k
Anneloes E. Bohte Netherlands	12	1.1k 0.6×	645 0.5×	240 0.7×	160 0.7×	216 1.4×	15	1.3k
Young Eun Chon South Korea	21	1.2k 0.6×	1.1k 0.8×	110 0.3×	206 0.8×	53 0.3×	76	1.5k
Kyu Sik Jung South Korea	22	1.4k 0.8×	1.2k 0.9×	130 0.4×	189 0.8×	44 0.3×	36	1.7k
Carmen Fierbințeanu‐Braticevici Romania	14	735 0.4×	447 0.3×	107 0.3×	273 1.1×	177 1.1×	57	1.1k
Amaury Mouries France	7	736 0.4×	507 0.4×	95 0.3×	133 0.5×	238 1.5×	8	1.0k

Countries citing papers authored by Faïza Chermak

Since Specialization

Citations

This map shows the geographic impact of Faïza Chermak's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Faïza Chermak with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Faïza Chermak more than expected).

Fields of papers citing papers by Faïza Chermak

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Faïza Chermak. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Faïza Chermak. The network helps show where Faïza Chermak may publish in the future.

Co-authorship network of co-authors of Faïza Chermak

This figure shows the co-authorship network connecting the top 25 collaborators of Faïza Chermak. A scholar is included among the top collaborators of Faïza Chermak based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Faïza Chermak. Faïza Chermak is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Dumortier, Jérôme, Filoména Conti, Jean‐Baptiste Hiriart, et al.. (2023). Treatment of donor-specific anti-HLA antibodies-mediated rejection after liver transplantation: A French nationwide retrospective study. Liver Transplantation. 29(12). 1313–1322. 7 indexed citations

Dutartre, Dan, Jean‐Baptiste Hiriart, Marie Irlès‐Depé, et al.. (2022). Long‐term prognosis of patients with metabolic (dysfunction)‐associated fatty liver disease by non‐invasive methods. Alimentary Pharmacology & Therapeutics. 55(5). 580–592. 12 indexed citations

Wong, Grace Lai–Hung, Jean‐Baptiste Hiriart, Ken Liu, et al.. (2019). Liver stiffness measurement predicts long‐term survival and complications in non‐alcoholic fatty liver disease. Liver International. 40(3). 581–589. 76 indexed citations

Boursier, Jérôme, Christophe Cassinotto, Gilles Hunault, et al.. (2018). Criteria to Determine Reliability of Noninvasive Assessment of Liver Fibrosis With Virtual Touch Quantification. Clinical Gastroenterology and Hepatology. 17(1). 164–171.e5. 10 indexed citations

Boursier, Jérôme, Christophe Cassinotto, Sarah Shili, et al.. (2018). Reliability criteria for liver stiffness measurement with ARFI. Journal of Hepatology. 68. S635–S635. 2 indexed citations

Boursier, Jérôme, J. Vergniol, Adrien Lannes, et al.. (2017). The combination of Fibroscan with blood markers in the fibrometerVCTE significantly reduces the use of liver biopsy for the assessment of advanced fibrosis in non-alcoholic fatty liver disease. Journal of Hepatology. 66(1). S161–S162. 1 indexed citations

Vergniol, J., Sébastien Duc, Guangdong Hou, et al.. (2016). Sexual quality of life is impaired in patients with chronic hepatitis C. International Journal of Impotence Research. 28(2). 68–73. 12 indexed citations

Boursier, Jérôme, Julien Vergniol, Jean‐Baptiste Hiriart, et al.. (2016). Diagnostic accuracy and prognostic significance of blood fibrosis tests and liver stiffness measurement by FibroScan in non-alcoholic fatty liver disease. Journal of Hepatology. 65(3). 570–578. 275 indexed citations

Cassinotto, Christophe, Anne Charrié, Amaury Mouries, et al.. (2015). Liver and spleen elastography using supersonic shear imaging for the non-invasive diagnosis of cirrhosis severity and oesophageal varices. Digestive and Liver Disease. 47(8). 695–701. 56 indexed citations

10.

Boursier, Jérôme, J. Vergniol, Jean‐Baptiste Hiriart, et al.. (2015). P0989 : A combination of elastometry and blood markers improves the non-invasive staging of liver fibrosis in NAFLD. Journal of Hepatology. 62. S717–S718. 1 indexed citations

11.

Cassinotto, Christophe, Bruno Lapuyade, Amaury Mouries, et al.. (2014). Non-invasive assessment of liver fibrosis with impulse elastography: Comparison of Supersonic Shear Imaging with ARFI and FibroScan®. Journal of Hepatology. 61(3). 550–557. 256 indexed citations

12.

Vergniol, Julien, Jérôme Boursier, Clélia Coutzac, et al.. (2014). Evolution of Noninvasive Tests of Liver Fibrosis Is Associated With Prognosis in Patients With Chronic Hepatitis C. Hepatology. 60(1). 65–76. 92 indexed citations

13.

Lédinghen, Victor de, Julien Vergniol, Maylis Capdepont, et al.. (2014). Controlled attenuation parameter (CAP) for the diagnosis of steatosis: A prospective study of 5323 examinations. Journal of Hepatology. 60(5). 1026–1031. 290 indexed citations

14.

Cassinotto, Christophe, Bruno Lapuyade, Julien Vergniol, et al.. (2013). Liver Fibrosis: Noninvasive Assessment with Acoustic Radiation Force Impulse Elastography—Comparison with FibroScan M and XL Probes and FibroTest in Patients with Chronic Liver Disease. Radiology. 269(1). 283–292. 96 indexed citations

15.

Trimoulet, Pascale, Patrícia Recordon-Pinson, Juliette Foucher, et al.. (2013). Dynamic and Rapid Changes in Viral Quasispecies by Udps in Chronic Hepatitis C Patients Receiving Telaprevir-Based Therapy. Antiviral Therapy. 18(5). 723–727. 11 indexed citations

16.

Wong, Grace Lai–Hung, Julien Vergniol, Peter Lo, et al.. (2013). Non-invasive assessment of liver fibrosis with transient elastography (FibroScan®): applying the cut-offs of M probe to XL probe. Annals of Hepatology. 12(4). 402–412. 29 indexed citations

17.

Wong, Vincent Wai‐Sun, Julien Vergniol, Grace Lai–Hung Wong, et al.. (2012). Liver Stiffness Measurement Using XL Probe in Patients With Nonalcoholic Fatty Liver Disease. The American Journal of Gastroenterology. 107(12). 1862–1871. 267 indexed citations

18.

Recordon-Pinson, Patrícia, Pascale Trimoulet, Juliette Foucher, et al.. (2012). 56 DYNAMICS OF HCV QUASISPECIES DURING TELAPREVIR TREATMENT DISSECTED USING ULTRA-DEEP PYROSEQUENCING: TREATMENT FAILURE IN 100% OF GENOTYPE 1A PATIENTS. Journal of Hepatology. 56. S25–S25. 2 indexed citations

19.

Lédinghen, Victor de, Vincent Wai‐Sun Wong, Julien Vergniol, et al.. (2011). Diagnosis of liver fibrosis and cirrhosis using liver stiffness measurement: Comparison between M and XL probe of FibroScan®. Journal of Hepatology. 56(4). 833–839. 185 indexed citations

20.

Pageaux, Georges‐Philippe, Stéphanie Faure, Faïza Chermak, Michaël Bismuth, & Hassan Bouyabrine. (2009). Discussion d’une transplantation hépatique chez un patient cirrhotique alcoolique incomplètement sevré. Gastroentérologie Clinique et Biologique. 33(10-11). F44–F49.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact